The invention discloses a preparation method of 6-aminocaproicacid which is a hemostatic.
本发明公开了一种止血剂6-氨基己酸的制备方法。
2
Results A total of 1343 patients (13.2%) received aprotinin, 6776 patients (66.8%) received aminocaproicacid, and 2029 patients (20.0%) received no antifibrinolytic therapy.